People who have hypertrophic cardiomyopathy (HCM) have access to comprehensive, personalized treatment at the UPMC Hypertrophic Cardiomyopathy (HCM) Center in Pittsburgh, Pa.
When you come to the HCM Center, you receive advanced care and coordinated services all at one location.
Hypertrophic cardiomyopathy (HCM) is a heart condition characterized by abnormal thickening (“hypertrophy”) of the heart muscle, most often in the main pumping chamber called the left ventricle.
In HCM, the hypertrophy is due to disorganized muscle fibers, most likely present at birth. Thickening is progressive and can eventually obstruct outflow of blood from the left ventricle to the body.
Since symptoms of HCM range from chest pain to sudden cardiac death, early treatment is a necessity. There is no definitive cure for HCM, but most people are able to live long, healthy lives under the care of their doctors.
At UPMC's Hypertrophic Cardiomyopathy (HCM) Center, people with HCM have access to:
Children with HCM can receive treatment at our clinic at UPMC Children’s Hospital of Pittsburgh.
People who have hypertrophic cardiomyopathy (HCM) have access to comprehensive, personalized treatment at the UPMC Hypertrophic Cardiomyopathy (HCM) Center in Pittsburgh, Pa.
When you come to the HCM Center, you receive advanced care and coordinated services all at one location.
Starting with the initial visit, you will meet with members of the HCM team for consultative, one-on-one services to develop your personalized treatment plan.
The Center's multidisciplinary team consists of:
These appointments most often can be coordinated with diagnostic imaging and cardiology testing in the same clinic on the same day.
The UPMC HCM Center is a designated center of excellence by the Hypertrophic Cardiomyopathy Association (HCMA), the only one of its kind in western Pennsylvania.
The physicians and scientists at the HCM Center are actively involved in ongoing research to advance patient care and develop new treatment options based on the latest research protocols.
UPMC Hypertrophic Cardiomyopathy (HCM) Center
Administrative Offices
Fifth floor, B-wing, Outpatient Cardiology Center
UPMC Presbyterian
200 Lothrop St.
Pittsburgh, PA 15213
Fax: 412-647-9996
Learn more about accommodations for patients traveling from outside the Pittsburgh area.
The UPMC Heart and Vascular Institute recently enrolled its first patient in the phase 2 MAVERICK-HCM clinical trial of mavacamten, a new drug in development to treat non-obstructive hypertrophic cardiomyopathy (HCM).
Read the press release.
Timothy Wong, MD, was featured in a story about diagnosing heart conditions in Pitt football players.
Read the story.